Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common complication of type 2 diabetes.
The US Food and Drug Administration (FDA) recently issued a notice of noncompliance to the FADOI Foundation, citing the organization’s failure
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic Act. The clause, in part, “prohibits the FDA from approving a color additive that is ingested if it causes cancer in animals or humans when ingested,” according to the agency .
There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as well as a lack of good old-fashioned common sense.
Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is seeking approval of Welireg for treating advanced,
In the final days of the Biden administration, the Food and Drug Administration (FDA) has taken a significant step toward reducing nicotine levels
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,
Discover which popular foods will be affected by the FDA's new ban on Red No. 3, the synthetic dye that adds a vibrant pop of color to candies, cakes, and some foods you wouldn't even expect.
The Food and Drug Administration (FDA) released a sweeping proposal Wednesday to try to make cigarettes less addictive by lowering the amount of nicotine they contain, an eleventh-hour plan from
First Aid Beauty has announced the recall of 2,756 jars of its Ultra Repair Cream in the coconut vanilla scent following an issue identified by the brand.
STATEN ISLAND, N.Y. — A popular brand of cookies has been recalled across the United States for containing “life-threatening' allergens, according to the Food and Drug Administration (FDA).
The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced.